Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of DS003 Vaginal Tablets in Healthy Women
NCT02877979Phase 1Completed
- Sponsor
- International Partnership for Microbicides
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing DS003 with Placebo (2 arms). Primary endpoint: Safety of DS003 vaginal tablets at 12 weeks. Started Nov 2015; status: completed.
02
Drugs
BMS-599793
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02877979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02877979.